Skip to main content
Funded Studies

Steve Zhang, PhD

Team Leader, Therapeutic Gene Regulation at Sangamo Biosciences, Inc.

Steve Zhang is currently Team Leader, Therapeutic Gene Regulation at Sangamo BioSciences Inc. He has a PhD in Molecular Genetics from Washington University, and has worked in the field of gene regulation for more than 10 years. Dr. Zhang's early research on transcriptional regulation in the context of cell cycle control has helped to elucidate the mechanism of the hallmark tumor suppressor protein, the retinoblastoma protein. Since joining Sangamo BioSciences in 2000, he has been focusing on developing novel therapeutics based on engineered transcription factors that regulate the expression of disease-related genes.

Associated Grants

  • Development of a Zinc Finger Protein Therapeutic for the Potential Treatment of Parkinson's Disease


  • Develop Engineered Zinc Finger Protein Transcriptional Activators of the Glial Cell Line-Derived Neurotrophic Factor (GDNF) Gene as a Potential Therapy for Parkinson's Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.